Patients who require hospitalization for COVID-19 are at an increased risk of developing conditions such as sepsis, acute lung injury (ALI), and acute respiratory distress syndrome (ARDS).1
Hemodynamic instability is a key contributor to mortality in patients with ARDS, and “successfully managing the complex hemodynamics of the ventilated patient with ARDS is key to patient survival.”2 The majority of patients needing ICU treatment will require mechanical ventilation.3 Existing evidence demonstrates critically ill patients who develop these complications are likely to develop multiple organ dysfunction syndrome (MODS) which significantly decreases the chance for patient survival, increases utilization of limited ICU and hospital resources, and ultimately results in an extended length of stay in both the ICU and hospital.4,5
Four phases of hemodynamic treatment in relation to cumulative fluid balance6
The rapidly changing and complex nature of critically ill patients requires continuous information to help guide the patient through the continuum of care, regardless of the chosen strategy for management. Hemodynamic monitoring can aid clinicians in their treatment of critically ill patients by providing information during the four phases in the time course of critical illness: rescue, optimization, stabilization, and de-escalation. The care modalities and goals of care vary substantially as the patient progresses through the care continuum.6
The use of hemodynamic monitoring during the rescue phase includes basic tools to monitor the patient in the initial minutes to hours of care. Continuous noninvasive pressure monitoring (including ClearSight finger cuff) can aid in hypotension management, as well as play a role in the early detection of sepsis, septic shock, and other shock states. Invasive pressure monitoring with disposable pressure transducers (including TruWave pressure transducers) aids in hypotension management and provides access for initial diagnostics, such as blood gases and other labs. In addition to continuous blood pressure, flow-based and dynamic parameters such as cardiac output (CO), stroke volume (SV) and stroke volume variation (SVV) can be obtained (e.g., FloTrac sensor/ ClearSight finger cuff) to give more insight into fluid resuscitation therapy than pressure-based parameters.3,6,7
Dynamic parameters can help identify the most appropriate initial therapy, such as helping clinicians decide between volume administration versus initiation of vasopressors. Additionally, advanced hemodynamic parameters provide valuable insight into the adequacy of perfusion, as blood pressure may be preserved despite the presence of inadequate tissue perfusion.7 Newer predictive technologies (Acumen Hypotension Prediction Index software) can now reliably predict a patient trending toward a hypotensive event.8
The optimization phase is time limited (generally up to the initial 24 hours) with the goal to reach optimal perfusion of peripheral tissue and repay any oxygen debt incurred through the course of illness.6 Routine use of arterial lines and central venous catheters are common in patients requiring ventilation and are recommended for therapy requiring vasopressors.7 Vasopressors or inotropes should be started only after an appropriate fluid challenge fails to restore organ perfusion.7
Balance of oxygen delivery and consumption9
Cardiac output and stroke volume monitoring and central venous oximetry monitoring (including EOCVC) are recommended in assessing individual patient response to fluids, vasopressors, or inotropes.7 More invasive monitoring, such as the Swan-Ganz pulmonary artery catheter, is indicated in more complex patients such as patients with refractory shock, ARDS, and right ventricular dysfunction.7 These devices provide additional parameters such as right-sided heart pressures, continuous mixed venous oximetry (SvO2), and volumetric parameters such as right ventricular ejection fraction (RVEF) and right ventricular end-diastolic volume (RVEDV).
Transpulmonary thermodilution technologies (such as VolumeView set) which provide additional parameters such as extravascular lung water (EVLW) may also be used where available.7
Hemodynamic monitoring may add additional value in this phase of care, as it allows sequential evaluation of the patient9 and their individual response to therapies.7 This may contribute to early identification of developing complications such as cardiac dysfunction and/or low flow states which may occur.7 For example, patients with ARDS are commonly managed with strategies which may negatively impact patient hemodynamics.1 Restrictive or conservative fluid management may result in inadequate tissue perfusion.10
Fluid imbalance leads to complications10
The use of dynamic parameters will allow identification of inadequate tissue perfusion when it occurs and help clinicians verify if fluid administration provides blood flow improvement. In the same regard, these parameters can help limit excess fluid administration when no improvement in blood flow is associated with fluid administration.11
Some therapies used to manage critically ill patients may contribute to inadequate perfusion. For example, the use of high PEEP ventilation is commonly used, and the excessive intrathoracic pressure created may negatively impact right ventricular function.2 Patients requiring high dose vasopressors to maintain adequate MAP may have adversely impacted SV and CO. Also, changes in patient positioning (such as prone therapy) may negatively impact blood flow.2 Other therapies to improve oxygenation, such as inhaled vasodilators, can also significantly alter patient hemodynamics.2
Finally, for the most critically ill patients requiring extracorporeal membrane oxygenation (ECMO), tissue oximetry monitoring (such as with ForeSight Elite sensor) may help allow early identification of cerebral desaturations and limb ischemia.12,13
As the patient progresses through the stabilization and de-escalation phases, the care shifts from aggressive resuscitation to a state of healing. Hemodynamic monitoring provides continuous data on the patient response during weaning of therapies such as mechanical ventilation, vasoactive medications, and removal of fluid to reduce any positive fluid balance.6 Additionally, hemodynamic monitoring may provide early recognition of developing complications such as sepsis, development of cardiac dysfunction, and hypotension.
In summary, advanced hemodynamic monitoring is highlighted as an essential element in a large variety of guidelines, recommendations, and standards of care for the critically ill patient.1,2,3,6,7
Hemodynamic education empowering clinical advancement
With a long-term commitment to improving the quality of care for critical care patients through education, Edwards clinical education meets you no matter where you are in the learning process — with a continuum of resources and tools that continuously support you as you solve the clinical challenges facing you today, and in the future.
Caution: Federal (United States) law restricts this device to sale by or on the order of a physician.
See Instructions For Use (IFU) / Directions For Use (DFU) for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.
Please update to a current version of your preferred browser, this site will perform effectively on the following:Unable to update your browser?
If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility